The Global Heart Transplant Market is expected to grow at a CAGR of 11.2% during the forecast period of 2017-2023.
Some of the key players in this market are
- SynCardia Systems, LLC (U.S.),
- HeartWare International Inc.,
- Apaxis Medical, Inc.,
- Calon Cardio,
- Optum Inc. (U.S.),
- Thoratec Corporation (U.S.),
- CardiacAssist Inc. (U.S.),
- CARMAT (France)
More than 3,000 people are on the waiting list for the Heart transplant on any given day. However, the number of heart donors is only 2,200 every year. There is a huge gap between the demand of the transplant procedures and the supply for the same. Chances of getting a matching donor and successful heart transplant are very slim for any patient. In this scenario, artificial heart transplant is the best possible chance for the patients for their survival. At this moment, there is only one FDA approved total artificial heart in the market which is manufactured by Syncardia Systems LLC.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/1836 .
Artificial heart transplant has emerged as a boon for the people in need for the heart transplant. It has created a hope for the patients who are desperately waiting for the heart transplant. Syncardia Systems Has played a humongous part in this revolutionary change in the treatment options for this severely critical procedure of heart transplant. Unfortunately, this procedure is currently being used less than 50 times per year as a bridge to heart transplant. According to the sources, there are at least 4 total artificial hearts under development. Hopefully, these new developments in the total artificial heart segment will counter all the difficulties in heart transplantation.
There is another noticeable development in the heart transplant business is the introduction of the OCS Heart Protable perfusion and monitopring system by TransMedics Inc. This system is the answer to the current cold storage heart preservation method, which increases the processing time and reduces transplantation ooutcome. OCS Heart System is believed to overcome these challenges and significantly improve patient outcomes, increase transplantation volume, and most importantly it can reduce the cost of the patient care. However, this system is not yet approved in United States, and is majorly used in the leading centers in Europe and Australia.
Heart Transplant Market – Regional Analysis
Globally North America is the largest market for heart transplant and is expected to reach to the further astronomical amounts attributing to the rising procurement of transplant diagnostic instruments among medical facilities.
Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/1836 .
Europe is the second-largest market for heart transplant which is expected to grow at a substantial CAGR. Asia pacific is expected to be the fastest growing Heart transplant market, owing to the burgeoning Medical Tourism market in the region.
1 Report Prologue
2 Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3 Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Heart transplant Market
Figure 3 Segmentation Market Dynamics for Heart transplant Market
Figure 4 Global Heart transplant Market Share, by Type 2016
Figure 6 Global Heart transplant Market Share, by End Users, 2016
Figure 7 Global Heart transplant Market Share, by Region, 2016
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/1836 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312